159 related articles for article (PubMed ID: 11305615)
1. Sensitizing effect of the phosphatidylinositol 3-kinase inhibitor wortmannin on thermal neutron irradiation with or without boron compound.
Kinashi Y; Sakurai Y; Masunaga S; Takagaki M; Ono K
Radiat Med; 2001; 19(1):27-32. PubMed ID: 11305615
[TBL] [Abstract][Full Text] [Related]
2. [The biological effect of the phosphatidylinositol 3-kinase wortmannin following thermal neutron irradiation].
Kinashi Y; Masunaga S; Suzuki M; Nagata K; Ono K
Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Sep; 63(8):405-8. PubMed ID: 14587410
[TBL] [Abstract][Full Text] [Related]
3. Ascorbic acid reduced mutagenicity at the HPRT locus in CHO cells against thermal neutron radiation.
Kinashi Y; Sakurai Y; Masunaga S; Suzuki M; Nagata K; Ono K
Appl Radiat Isot; 2004 Nov; 61(5):929-32. PubMed ID: 15308170
[TBL] [Abstract][Full Text] [Related]
4. A bystander effect observed in boron neutron capture therapy: a study of the induction of mutations in the HPRT locus.
Kinashi Y; Masunaga S; Nagata K; Suzuki M; Takahashi S; Ono K
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):508-14. PubMed ID: 17418970
[TBL] [Abstract][Full Text] [Related]
5. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
6. Bystander effect-induced mutagenicity in HPRT locus of CHO cells following BNCT neutron irradiation: characteristics of point mutations by sequence analysis.
Kinashi Y; Suzuki M; Masunaga S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S325-7. PubMed ID: 19375934
[TBL] [Abstract][Full Text] [Related]
7. In vitro neutron irradiation of glioma and endothelial cultured cells.
Menichetti L; Gaetano L; Zampolli A; Del Turco S; Ferrari C; Bortolussi S; Stella S; Altieri S; Salvadori PA; Cionini L
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S336-40. PubMed ID: 19410472
[TBL] [Abstract][Full Text] [Related]
8. [Neutron capturing irradiation: principle, current results and perspectives].
Pignol JP; Chauvel P
Bull Cancer Radiother; 1995; 82(3):283-97. PubMed ID: 8554878
[TBL] [Abstract][Full Text] [Related]
9. Dimethyl sulfoxide protects against thermal and epithermal neutron-induced cell death and mutagenesis of Chinese hamster ovary (CHO) cells.
Kinashi Y; Sakurai Y; Masunaga S; Suzuki M; Akaboshi M; Ono K
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1371-8. PubMed ID: 10889392
[TBL] [Abstract][Full Text] [Related]
10. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
11. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
12. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
[TBL] [Abstract][Full Text] [Related]
13. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
14. Feasibility study on the utilization of boron neutron capture therapy (BNCT) in a rat model of diffuse lung metastases.
Bakeine GJ; Di Salvo M; Bortolussi S; Stella S; Bruschi P; Bertolotti A; Nano R; Clerici A; Ferrari C; Zonta C; Marchetti A; Altieri S
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S332-5. PubMed ID: 19394841
[TBL] [Abstract][Full Text] [Related]
15. EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation.
Kullberg EB; Wei Q; Capala J; Giusti V; Malmström PU; Gedda L
Int J Radiat Biol; 2005 Aug; 81(8):621-9. PubMed ID: 16298943
[TBL] [Abstract][Full Text] [Related]
16. Combination of boron and gadolinium compounds for neutron capture therapy. An in vitro study.
Matsumura A; Zhang T; Nakai K; Endo K; Kumada H; Yamamoto T; Yoshida F; Sakurai Y; Yamamoto K; Nose T
J Exp Clin Cancer Res; 2005 Mar; 24(1):93-8. PubMed ID: 15943038
[TBL] [Abstract][Full Text] [Related]
17. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric evaluation of neutron capture therapy for local advanced breast cancer.
Yanagie H; Kumada H; Sakurai Y; Nakamura T; Furuya Y; Sugiyama H; Ono K; Takamoto S; Eriguchi M; Takahashi H
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S63-6. PubMed ID: 19427224
[TBL] [Abstract][Full Text] [Related]
19. A novel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: in vitro and in vivo studies.
Jori G; Soncin M; Friso E; Vicente MG; Hao E; Miotto G; Colautti P; Moro D; Esposito J; Rosi G; Nava E; Sotti G; Fabris C
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S321-4. PubMed ID: 19376726
[TBL] [Abstract][Full Text] [Related]
20. Calibration of the borated ion chamber at NIST reactor thermal column.
Wang Z; Hertel NE; Lennox A
Radiat Prot Dosimetry; 2007; 126(1-4):626-30. PubMed ID: 17525059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
